Literature DB >> 15480879

Alternative splicing in the N-terminus of Alzheimer's presenilin 1.

Wiep Scheper1, Rob Zwart, Frank Baas.   

Abstract

Presenilin 1 (PS1) is mutated in the majority of familial cases of Alzheimer disease (AD). Although it is clear that PS1 is involved in the processing of the amyloid precursor protein (APP), the exact function of PS1 is still elusive. Human presenilin 1 (PS1) is alternatively spliced, resulting in the presence or absence of a four-amino acid motif, VRSQ, in the PS1 N-terminus. In human tissues, both isoforms are expressed. Here we report that mouse and rat only express the longer PS1 isoform. The presence of this motif introduces a potential phosphorylation site for protein kinase C. Because the splice occurs in the region of PS1 that we have previously shown to bind to rabGDI, this might provide a regulatory mechanism for this interaction. Our data show that the -VRSQ isoform binds rabGDI, but the +VRSQ does not. Moreover, mutation of the putatively phosphorylated threonine in PS1 disrupts the binding to rabGDI, showing its importance for the interaction. To our knowledge this is the first study showing a functional difference between PS1 splice variants. The possible consequences for APP processing and the pathogenesis of AD are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480879     DOI: 10.1007/s10048-004-0195-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  24 in total

1.  Molecular cloning, sequencing, and brain expression of the presenilin 1 gene in Microcebus murinus.

Authors:  A Calenda; N Mestre-Francés; C Czech; L Pradier; A Petter; N Bons; M Bellis
Journal:  Biochem Biophys Res Commun       Date:  1996-11-12       Impact factor: 3.575

Review 2.  Rab GDP dissociation inhibitor: putting rab GTPases in the right place.

Authors:  S R Pfeffer; A B Dirac-Svejstrup; T Soldati
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

3.  Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.

Authors:  D G Cook; M S Forman; J C Sung; S Leight; D L Kolson; T Iwatsubo; V M Lee; R W Doms
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

4.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

5.  Alzheimer's presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor.

Authors:  W Scheper; R Zwart; P van der Sluijs; W Annaert; W A Gool; F Baas
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

6.  Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease.

Authors:  E I Rogaev; R Sherrington; C Wu; G Levesque; Y Liang; E A Rogaeva; M Ikeda; K Holman; C Lin; W J Lukiw; P J de Jong; P E Fraser; J M Rommens; P St George-Hyslop
Journal:  Genomics       Date:  1997-03-15       Impact factor: 5.736

Review 7.  Learning and memory deficits in APP transgenic mouse models of amyloid deposition.

Authors:  Dave Morgan
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

8.  Protein topology of presenilin 1.

Authors:  A Doan; G Thinakaran; D R Borchelt; H H Slunt; T Ratovitsky; M Podlisny; D J Selkoe; M Seeger; S E Gandy; D L Price; S S Sisodia
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

9.  gamma-Aminobutyric acidA receptor heterogeneity is increased by alternative splicing of a novel beta-subunit gene transcript.

Authors:  A N Bateson; A Lasham; M G Darlison
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

Review 10.  Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices.

Authors:  R M Nitsch; B E Slack; S A Farber; J G Schulz; M Deng; C Kim; P R Borghesani; W Korver; R J Wurtman; J H Growdon
Journal:  J Neural Transm Suppl       Date:  1994
View more
  10 in total

Review 1.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

2.  Structural genomics analysis of alternative splicing and application to isoform structure modeling.

Authors:  Peng Wang; Bo Yan; Jun-Tao Guo; Chindo Hicks; Ying Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

Review 3.  Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Authors:  Kathleen F Mittendorf; Catherine L Deatherage; Melanie D Ohi; Charles R Sanders
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

4.  Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sábat; José I Lao; Cristina Carrato; Isidro Ferrer; Aurelio Ariza
Journal:  Neurogenetics       Date:  2007-10-23       Impact factor: 2.660

5.  Model-based detection of alternative splicing signals.

Authors:  Yoseph Barash; Benjamin J Blencowe; Brendan J Frey
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

6.  The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes.

Authors:  Mathew J Sharman; Seyyed H Moussavi Nik; Mengqi M Chen; Daniel Ong; Linda Wijaya; Simon M Laws; Kevin Taddei; Morgan Newman; Michael Lardelli; Ralph N Martins; Giuseppe Verdile
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  It all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease.

Authors:  Amit Berson; Hermona Soreq
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

8.  The unfoldomics decade: an update on intrinsically disordered proteins.

Authors:  A Keith Dunker; Christopher J Oldfield; Jingwei Meng; Pedro Romero; Jack Y Yang; Jessica Walton Chen; Vladimir Vacic; Zoran Obradovic; Vladimir N Uversky
Journal:  BMC Genomics       Date:  2008-09-16       Impact factor: 3.969

9.  Prediction of Disordered Regions and Their Roles in the Anti-Pathogenic and Immunomodulatory Functions of Butyrophilins.

Authors:  Elrashdy M Redwan; Ahmed M Al-Hejin; Hussein A Almehdar; Abdelrahman M Elsaway; Vladimir N Uversky
Journal:  Molecules       Date:  2018-02-04       Impact factor: 4.411

Review 10.  Molecular pathology of Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Aurelio Ariza
Journal:  Int J Mol Sci       Date:  2009-02-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.